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It is dear  that  anti-A and  anti-B  are sometimes 7A-globulin  (1-3)  but  evi- 
dence  about  other  blood  group  antibodies  is  conflicting.  The  purpose  of  the 
present work was first to find out more about the serological characteristics  of 
3,A-anti-A and anti-B and second to search for 3,A-isoantibodies of other blood 
specificities. In view of the fact that  ~,A-globulin is present  in relatively large 
amounts in saliva and colostrum (4, 5), these secretions, as well as serum, were 
examined. 
Methods 
Donors of Anti-A and Anti-B.-- 
Sdevted potent antisera: Five sera were selected; 4  were from group  O women who had 
given birth to infants severely affected with hemolytic disease; 2  of the women (Bey. and 
Bak.)  had each given birth to three infants affected with severe hemolytic disease due to A 
incompatibility; the 3rd (Byr.) had given birth to one infant with moderately severe hemolytic 
disease due to A incompatibility; and the 4th (Vel.) had given birth to one infant with hemo- 
lytic disease due to A incompatibility followed by one with hemolytic disease due to B  in- 
compatibility. The 5th serum was from a male group O subject who had been given two sub- 
cutaneous injections, each of 2 mg of group B  substance,  at an interval of 7 days and had 
been bled 10 days after the second injection. 
Anti-A and ant~-B in colostrum and serum: Samples of colostrum and serum were collected 
from 17 "random" mothers (8 group A, 6 group O, and 3 group B), between 3 days before and 
1 day after delivery; the method of treating the colostrum is described below. Blood samples 
were taken from the same women by venepuncture within 2 days of delivery; the serum was 
separated from dotted blood as soon as possible and stored at  --50°C if not tested immediately. 
Anti-A  and anti-B  in saliva and serum: Samples of saliva and serum were obtained from 
8 group O, 9 group A, and 7 group B normal subjects and examined for the presence of ~'A- 
anti-A or anti-B as described below. 
Donors of Anti-Rh.-- 
Ang-D:  Sera were regarded as containing anti-D when they reacted with D-positive red 
cells and not with D-negative red cells; no attempt was made to distinguish between anti-D 
and anti-CD etc. 
From 25 women immunized to R]a(D)  by pregnancy,  serum alone was tested;  11  of the 
women had had at least one very severely affected infant  (stillbirth, or live birth with cord 
hemoglobin concentration less than 9 g/100 ml). 
One woman  (Avg.)  proved to be of special interest and for this reason further details of 
her history are given. She was born in 1909. Between 1934 and  1948 she gave birth to four 
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infants with Rh hemolytic disease including two stillbirths. Some time between 1945 and 1949 
she was diagnosed as having hereditary spherocytosis and during this period was transfused 
with 28 units of blood. It is possible that some of the units transfused in 1945 may have been 
Rh positive. Splenectomy was carried out in 1949.  She later developed hemochromatosis and 
between January 1961 and May 1962 approximately 35 liters of her blood were removed by 
venesection. During the subsequent 18 months the total amount of blood taken was less than 
3 liters. In the middle of the course of venesection the patient agreed to receive some small 
injections of Rh-positive red cells in the hope of increasing the titer of Rh antibody in her 
serum. Further details are given below in Results. 
From 5 additional women immunized by pregnancy to Rh(D), colostrum as well as serum 
was tested and in two of these eases saliva, obtained 7 days after delivery, was also tested. 
Serum from 2 male subjects immunized by blood transfusion was examined; 1 patient had 
been transfused with Rh(D)-positive blood 7 yr previously and was examined 1 month after 
he had received a  second transfusion of  D-positive blood.  The other patient had received 
transfusions of D-positive blood 3 yr previously and probably also 16 and 24 yr previously. 
Anti-c:  Two women with antic in their serum were examined;  1 woman had been im- 
munized by pregnancy alone and the other by blood transfusion followed by pregnancy which 
resulted in a macerated stillbirth. 
Sera Containing  Antibodies  Other Than Those of the ABO and Rtt Systems.--Three sera con- 
taining Lewis antibodies were tested; 1 (containing anti-Le  b and anti-Le  a) was from a subject 
(Cri.) who had received transfusions of Le(a+)  plasma, injections of purified Le a and Le b 
substances and transfusions of Le(b+) red cells (6); the 2nd (containing anti-Le  a only) was 
from a  subject (Bur.) who had received transfusions of Le(a+) blood as well as injections of 
Le(a+) red cells (7); the 3rd, (Spe) kindly provided by Miss Carolyn Giles, contained mainly 
anti-Le  a with a  trace of anti-Le  b and came from a woman who had never been transfused or 
been pregnant. 
Three sera containing anti-K, 3 containing anti-Fy  a, and 3 containing anti-Jk  a were also 
tested; all the subjects had been immunized by incompatible blood transfusions. 
Cdlection  and  Treatment  of Colostrum and  Sali~a.--Colostrum  was collected by simple ex- 
pression of the breast, between 3 days before and 1 day after delivery; the sample was cen- 
trifuged and the fatty layer removed; the eentrifuged colostrum was then adjusted to pH 4.6 
with acetic acid and the precipitate (casein) removed by centrifugation; the superuatant was 
adjusted to pH 7.4 with a  solution of sodium hydroxide and stored at  -20°C.  (5). 
In collecting saliva, the subject was asked to provide at least 2 ml in a  clean beaker. The 
sample was centrifuged and any deposit discarded. The superuatant was stored at  --20°C 
for not more than 3  days before being tested.  ~o  volume of 5% NaC1 was added to each 
sample to ensure that it would not be so hypotonic as to lyse red cells. 
Sera  Used as a Source of Complement.--Fresh  group O serum containing low titer anti-A 
and anti-B was absorbed at 0°C three times with group A  or group B  red cells,  previously 
washed three times with buffered saline. 
Guinea pig serum, separated as soon as possible from freshly drown blood, was absorbed 
once, at 0°C with human red cells. 
Human Group A  and  B  Substances.--Purified group A  and B  substances, prepared from 
pseudomucinons ovarian cyst fluids,  was kindly provided by Professor W. T. J.  Morgan. A 
solution containing 2 mg per 1 ml was used in the inhibition tests. 
DEAE-Cdlulose  Ckromatography.--Step-wise  elution  with  phosphate  buffers  was  used 
throughout. Two methods of fractionating the serum were used: In  "method A"  the first 
buffer was 0.0175  ~r, pH 6.5 and the following buffers were: 0.04; 0.06; 0.08; 0.12; 0.14; 0.16; 
and 0.2 ,~, at pH 8.1. In "method B" only three buffers were used: 0.0175  M, pH 6.5; 0.08 M, 
pH 8.1; and 0.2 M pH 8.1. The proteins eluted in each fraction were concentrated by pressure ADINOL~'I~ MOLLISON~ POLLF.y~  AND  ROSE  953 
dialysis and dialyzed against "buffered saline",  (0.85% sodium chloride buffered with phos- 
phate to pH 7.4). 
Colostrum was fractionated following the method suggested by Tomasi  et al.  (5); thus 
three phosphate buffers were used: (a) 0.01 ~, pH 7.5; (b) 0.1 M, pH 6.4; and (c) 0.3 M, pH 4.7. 
A single protein peak was obtained with eluants a and c but a double peak with eluant b, so 
that in all, four protein peaks were collected. The proteins present in each fraction were con- 
centrated as in the method used for the serum fractions. 
Treatment with 2-Mereaptoetkarug (2-ME).--1 volume of serum, colostrum or fraction, was 
mixed with an eqtml volume of 0.1 ~t 2-ME in phosphate buffer pH 7.4 and left at 37°C for 
2 hr. Iodoacetamide in phosphate buffer was then added to a final molarity 0.05.  The mixture 
was left at 0°C for 15 rain and then dialyzed against buffered saline at 4°C. As a  control, 1 
volume of serum, or colostrum or fraction, was treated with buffer alone in the same way. 
Heating at 56°C for Various Periods of Time.--Aliquots of colostrum diluted with an equal 
volume of buffered saline, and the 0.017, 0.08, and 0.2 M fractions prepared from Bak. serum, 
were heated at 56°C for 1, 2, and 3 hr. 
Anti-A and AUti-B A gglutlnins and Hemolysins.--In testing anti-A and anti-B agglutlnln~ 
serial doubling dilutions of serum, colostrum, or saliva were incubated for 1~ hr with a sus- 
pension of appropriate red cells in saline. In testing serum and colostrum 1 volume was mixed 
with 1 volume of a  2% red cell suspension but in testing saliva, because the aggintinin titers 
were low, 4 volumes of saliva (or of a dilution of saliva) were mixed with 1 volume of red cell 
suspension. 
In testing the hemolytic activity of eolostrum, and of fractions of colostrum or serum, fresh 
complement was supplied. 4 volumes of each of a series of doubling dilutions of the antibody- 
containing samples were incubated at 37°C for 10 rain with 2 volumes of complement and 1 
volume of a  10% suspension of group A or B  red cells.  The tubes were spun and the degree 
of hemolysis scored. This method is referred to as the "one-stage" method. 
In the "two-stage" method red cells were first sensitized with antibody, washed, and then 
incubated at  37°C  with complement. Thus  4  volumes of  colostrum,  of  serum  (previously 
heated at 56°C for 20 rain) or of fractions of colostrum or serum were incubated at 37°C for 
90 rain with 1 volume of a  10% suspension of appropriate red cells.  The sensitized red cells 
were then washed three times with ice-cold saline and resnspended in saline to give a  10% 
suspension. 2 volumes of complement were added to each tube and the mixture incubated at 
37°C for 30 rain. 
Enhancement of Agglutination in Serum.--Serial dilutions of serum, colostrum, or fractions 
were prepared using as a diluent group O serum, heated at 5CC for 15 rain and then absorbed 
three times with group A and B red cells, and finally diluted with an equal volume of buffered 
saline. 
Inhibition  of AUti-A Agglutinin with A  Substance.--The  anti-A agglutinin present in colos- 
trum (Roo.) and in the 0.0175, 0.08,  and 0.2 M fractions of Bak. serum was tested before and 
after inhibition with various dilutions of A substance. The procedure used was similar to that 
described previously by Policy et al. (8). 
Indirect  AntiglobuUn  Tests  and  Estimation  of "yG-, 'yA-,  and  'yM-Globulins.--Auti-'yA: 
Four different sera were used. The first, kindly supplied by Dr. J. F. Soothill, had been made 
in a  rabbit, by injecting urine from a  patient with "yA-myelomatosis. The second,  kindly 
supplied by Professor S. Cohen, had been made in a rabbit by injecting serum from a patient 
with 7A-myelomatosis; the remaining two sera were purchased from Hoechst Pharmaceutical 
Company, Frankfurt, Germany, and had been made by injecting ~,A-globulin from normal 
human serum into a  rabbit and a  goat respectively. 
The samples of anti-qtA were made specific by adding qtG-globulin; after the treatment the 
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against human serum or a 5~A-globulln preparation kindly provided by Dr. S. Cohen; no line 
of precipitation was observed when the immune sera were tested against cord serum. 
The immune sera did not agglutinate Rh-positive red cells sensitized with an incomplete 
anti-D eluted in the 0.0175 M fraction. As described in Results the specificity of the anti--3'A- 
globulin sera was confirmed by showing that the reaction against Rh-posltive red cells sensi- 
tized with an incomplete anti-D "/A-antibody was not inhibited by cord serum. 
Anti-~/G: Sera obtained by injecting highly purified human 5'G-giobulln into sheep and 
rabbits were used. The antisera contained 3 to 5 mg anti-3'G and contained no demonstrable 
antibodies against other human serum proteins (9). 
Anti-3"M: Two sera obtained by injecting human pathological 5'M-globulin into rabbit 
were used; the immune sera were made specific by treatment with 7G-globtdin (10). 
Anti-fll~. and anti-~lc  (anti-CO: Two sera were used: an anti-fll~-globulln serum  (M59) 
described by Polley et al. (11) and an anti-/~xE- q- anti-file-globulin serum (M 65), prepared 
as follows.  Rabbit red cells were first sensitized with EDTA-treated horse serum, then washed 
and incubated at 37°C for 30 min with human fresh serum which had been previously ab- 
sorbed with rabbit red cells and treated with zymosan (1 ml serum/3 mg zymomn type A) at 
37°C. Several injections of red cells treated in this way were given intravenously to a rabbit. 
For convenience the anti-/~lw- and anti-/31E -[- anti-~xc-sera are referred to collectively as 
anti-C' globulin sera. 
I~lirect  Antiglobulin  Tests.--The  anfi-~G-  and  anti--'yM-giobulin tests  were  made  as 
previously described (9), and a  similar method was used with anti-'yA (12); the dilutions of 
anti-'yA-globulin serum used ranged from  1:50 to  1:200 and were  those found optimal in 
testing Rh-positive red cells sensitized with an incomplete anti-D TA-antibody (see Results). 
The anfi-C' globulin tests were carried out using a  two-stage method (13); thus 1 volume 
of a 20% suspension of red cells was incubated at 37°C for 90 rain with 4 volumes of EDTA- 
treated serum (1 ml serum/4 nag EDTA) containing the incomplete antibody and then washed 
three times with buffered saline; the sensitized red cells were then incubated at 37°C for 20 
rain with 2 volumes of human complement. After being washed, the red cells were tested with 
a suitable anti-C' globulin serum. 
Estimation  of the Degree of Agglutina~ion.--In the present paper the results of  titrating 
antibodies are expressed either as an "end point" using the reciprocal of the last dilution of 
serum to show agglutination or as a  "score" (14).  In comparative titration the score method 
was found to be the more useful way of describing the pattern of an antibody in serum or 
fractions (14, 15). 
Estimation of "yG, "yM, and "~A.--The  amounts of these three immunoglobulins in serum, 
colostrum, saliva, and in fractions obtained by DEAE-cellulose chromatography were  esti- 
mated by the inhibition of antiglobulin serum method as previously described (16,  10). 
"yA was estimated by inhibiting the reaction between anti-'yA and red cells sensitized with 
a  particular anti-Rh serum (Avg.) which, as described below, was partly TA and partly 'yG 
(12). 
Elation of Antibody from Red Cells.--The  method of Rubin (17), slightly modified (18), was 
used in an attempt to demonstrate that anti-A eluates, prepared from A red cells incubated 
with colostrum, contained predominantly "yA-globniln.  In order to avoid interference from 
proteins absorbed nonspecifieally onto the red cells and subsequently eluted, antibody was 
first eluted into 10% albumin; red cells were then sensitized with this eluate and a  second 
elution performed. The concentration of "yA- and 3'G-globulin in the second eluate was then 
estimated. An eluate prepared in the same way from group O red cells provided a  control. 
RESULTS 
"rA-Globulin in Cord Serum, Colostrum, Saliva, and in the Fractions Obtained 
from  DEAE-Cellulose.--In  the  present  work  estimations  of  ~'G-, ~/A-, and AD1.NOL~'I~ MOLLISON,  POLLEY,  AND  ROSE  955 
~M-globulin in cord serum are expressed as percentages of the amounts present 
in the corresponding maternal serum; those in colostrum and saliva are  ex- 
pressed as percentages of the amounts present in the serum of a normal adult 
donor (Adi.) and those in the fractions obtained from DEAE-cellulose are ex- 
pressed as percentages of the amount of "/G-, "yA-, and "l,M-globulins  present 
in the original sample of serum or colostrum. 
Table I  shows the results. In the eight cord sera the concentration of "yA- 
globulin  was  always less  than 0.1%  of that  in  the  corresponding maternal 
serum.  In  the  four  samples  of  colostrum  the  concentration  of "),A-globulin 
ranged from 50 to 100 % and in four salivas from 10 to 20 % of the amount in 
normal serum. 
The amount of ~,G-globulin in the four samples of colostrum was less than 
1% of the amount in normal serum; only traces of -~,G-globulin were present 
TABLE I 
Amount of ~/G, 'TM, and "yA in Cord Serum, Colostrum, and Saliva, Estimated by Inhibiting 
Spedf~ Antiglobulin Rec~tions 
No. tested  Samples 
Cord serum 
Colostrum 
Saliva 
Amounts present in normal adultsera* 
q/G 
% 
120~ 
0.2-0.6 
0.1 
5"A 
% 
0.1 
50-100 
10-20 
5'M 
% 
S-20~ 
5-10 
1-3 
* Cord serum results expressed as percentages of concentrations in relevant maternal 
serum. 
~: From Polley et al. (9). 
in the salivas tested. Similarly, only small amounts of "yM-globulin were found 
in colostrum and saliva. 
The results of estimating ~,A-globulin in the DEAE fractions obtained from 
serum using method A showed that about 40 to 50% of ~,A-globulin was re- 
covered in the 0.08 ~  fraction, 20 % in the 0.06 M fraction and 2 % in the 0.04 
fraction (see Fig. 1). Using method B, 50 to 80% of ~A-globulin was recov- 
ered in the 0.08 M fraction (see Table IV). 
As mentioned in Methods four protein peaks were observed when colostrum 
was fractionated by DEAE-cellulose chromatography, since the 0.1  ~  buffer 
consistently resolved the colostrum protein into two peaks. The four fractions 
collected will be referred to as 0.01 ~, 0.1 M(a), 0.1 M(b), and 0.3 ~. 
The results of estimating ~,A-globulin in these fractions showed that about 
50% of ~A-globulin was recovered in the 0.1 M(a) fraction and 20% in the 0.1 
~(b) fraction; ~,G-globulin was recovered in the 0.01 ~  fraction and less than 
1% of the "yG-globulin present in whole colostrum was present in the other 
three fractions (see Table III). 956  "/A-BL00D  GROUP ANTIBODIES 
Frequency of Anti-A and Anti-B Antibodies in Colostrum.--I_n all but one of 
the samples  of colostrum tested,  all expected isoagglut'mins were present;  the 
exceptional sample (lacking anti-B) was from a group A mother who had given 
birth to a premature infant at 31 wk following induction of labor. 
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FIG. 1. Amounts of ~gM-, ~/A-, and TG-globulin, as percentages of the amounts  present 
in whole serum,  in fractions  separated  on DEAE-cellulose, using the following phosphate 
buffers as eluants:  (a), 0.0175 5; (b), 0.04 ~; (c), 0.06 ~; (d), 0.08 ~r; (e), 0.12 ~; (/), 0.14 ~r; 
(g), 0.16 ~r; and (h), 0.2 ~. 
The lower part of the figure shows the pattern of total protein einted in the various frac- 
tions. 
In 10 out of 16 cases in which isoagglutinins were present  in colostrum the 
titer  was higher than  in serum from the same subject;  and in  the  remaining 
6 cases the titer was either the same or slightly lower in colostrum. The titers 
in colostrum, expressed as mean scores were as follows: in 8 group O mothers: 
anti-A,  62.5,  anti-B,  48.0;  in 3  group B  mothers: anti-A  57.3;  in 8  group A 
mothers: anti-B, 43.1. 
Frequency of Anti-A and Anti-B Antibodies in Saliva.--The anti-A agglutinin ADINOL]~I, MOLLISOlq~ POLLEY, AND ROSE  957 
was present in 7 out of 8 salivas from group O donors and in 6 out of 7 salivas 
from group B  donors. The anti-B agglutinin was present in 5 out of 8 salivas 
from group O donors and in 3 out of 9 salivas from group A donors. 
Mean scores were as follows: group O donors: anti-A, 15.0, anti-B, 7.7; group 
A donors: anti-B, 6.2; group B  donors: anti-A 10.1. 
Anti-A  and Anti-B Antibodies in Fractions  Eluted from DEAE-CeUulose.-- 
Selected  potent  group  0  sera:  Table II shows the results of testing the 0.08 
x~ fractions which were found to contain the bulk of 7A-globulin.  In 2  (Bey. 
and Byr.) out of the 5 sera, no anti-A or anti-B could be detected in the 0.08 
u  fraction but in the remaining 3 the fraction agglutinated red ceils to a  titer 
of 16 to 32. 
Anti-~G did not enhance the agglutination of red cells sensitized with frac- 
TABLE II 
Results of Testing the 0.08 ~ Fractions  from DEAE-CeUUlose  from Five Sdeded Sera  Containing 
Potent Anti-A or Anti-B 
Bak.  (anti-A) 
Bey. 
Byr. 
Vel.  " 
Win.~ (anti-B) 
Indirect antiglobulin titer 
Anti-TA 
256 
0 
0 
64 
128 
Anti-TG 
128 
0 
0 
16 
32 
Saline control* 
64 
0 
0 
16 
32 
* As a control each sample of sensitized red cells was tested with saline as well as with 
the specific sntiglobulin sera. 
SThe first 4 sera were fractionated using "method A'; the 5th serum (Win.) was frac- 
tionated using "Method B". 
tions obtained from serum Vel. and serum Win.; since the indirect antiglobulin 
titer  of 7G-anti-A  and  anti-B  is usually  five dilution  steps higher  than  the 
agglutination titer in saline (7) it was evident that these fractions contained no 
more than a  trace of 7G-anti-B.  The fact that  the antibody was mainly ~A 
was indicated  by distinct  enhancement  (two dilution  steps)  on  adding  anti- 
~A.  The anti-A in  the 0.08 M fraction from the serum Bak.  was slightly en- 
hanced by anti-~G and enhanced  to a  greater extent by anti-~A; it thus  ap- 
peared  that 7A-anti-A  was  the  predominant  antibody  although  some  ~G- 
anti-A  was  probably  also  present. 
Four  samples of  colostrum,  three  from group  A  donors  (Law.,  Fee.,  and 
Whi.)  and one from a  group B  donor (Roo.) were fractionated. 
It was found that anti-A and anti-B agglutinins present in colostrum were 
recovered both in the 0.1 ~(a) and 0.1 M(b) fractions, which together contain 
the bulk of 7A-globulin. No anti-A or anti-B was found in the 0.01 ~r fraction; 958  "/A-BLOOD  GROUP  ANTIBODIES 
in two out of the four samples tested, low titer agglutinins were found in the 
0.3 M fraction (Table III). 
In two of  the group A  sera fractionated, the  anti-B agglutinin was found 
only in the 0.2 ~  fraction. 
Serological  Properties of ~,A-Anti-A  and Anti-B.--The  serological properties 
TABLE III 
Results of Testing Anti-A  and Anti-B Agglutinins in DEAE-Cellulose Fractions Prepared 
from ColosCrum 
Whole colostrum ......... 
Fraction 0.01 x¢ .......... 
Fraction 0.1 xt(a) ......... 
Fraction 0.1 g(b) ......... 
Fraction 0.3 xr ........... 
Content* of 
"yG-globulin 
100 
50 
1 
1 
1 
,yA-globulin 
100 
2 
50 
20 
2 
Anti-A or anti-B agglutinins~ in: 
I  Law.  I  Fee.  Whi. 
anfi-B  anti-B  anti-B 
67  [  121  38 
i 
22 
5  I  0  0 
8  0  0 
ROO. 
anti-A 
77 
0 
38 
25 
0 
* The content of "yG- and 3,A-globulin  present in the fractions is expressed as a percentage 
of the amount present in whole colostrum. 
~/The figures represent  "scores"  (see text). 
TABLE IV 
Results of Testing A nti-B DEA E-Cellulose Fractions Prepared  from Serum "Win." 
Whole serum ............... 
Fraction 0.0175 M  ........... 
Fraction 0.08 M  ............. 
Fraction 0.2 M  .............. 
Content* of 
~G  V____~A  V~ 
j  ioo  [  1oo 
s  82  611 
2  I  21100 
Agglutination~  Hemolysis~ 
152  51 
37  23 
38  0 
131  39 
* Expressed as a percentage of the content in whole serum. 
Results expressed as "scores". 
of  ~/A-isoagglutinins were  studied  either by testing samples of  colostrum in 
which the isoagglutinins  had been shown to be present only in association with 
~,A-globnlin  or by testing fractions prepared from selected sera. 
Complement-Binding  Activity  of 3,A-Anti-A  and Anti-B.--Four  samples  of 
colostrum and fractions prepared from serum Win. were tested for hemolytic 
activity. It was  found that  the four samples of  colostrum did not hemolyze 
group A or B  red cells either when the red ceils were incubated with colostrum 
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were first sensitized with EDTA-treated colostrum and then exposed to human 
complement ("two-stage" method). It was also found that the 0.08 M fraction 
prepared from Win. serum did  not hemolyze group  B  red cells although the 
agglutinin titer of this fraction was very similar to that in the 0.0175 ~ fraction 
which did hemolyze group B red cells (Table IV). 
Further tests were carried out to see whether vA-anti-A and anti-B were 
capable of binding complement components using the two-stage test (see Meth- 
ods) in which cells are first incubated with  antibody then with  complement 
and finally tested with C' globulin serum. 
Addition of anti-C' globulin serum never increased the titer of fractions con- 
TABLE V 
Effect of Using Saline and Serum as Diluents in Titrating Anti-B Present in Serum 
or Colostrum 
Serum Win. 
ColostrumRei. 
DEAE-cellulose ] 
fraction 
0.0175 M 
0.08 M 
0.2M 
Untreated 
Diluent 
Saline 
Serum 
Saline 
Serum 
Saline 
Serum 
Saline 
Serum 
+++ 
+++ 
++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Dilutions  (reciprocals) 
++ 
+++ 
(+) 
++ 
+++ 
+++ 
++ 
+++ 
32 
+ 
+++ 
+ 
++ 
++ 
+ 
++ 
128 
++ 
m 
(+) 
+ 
+ 
(+) 
+ 
512  2000 
+  - 
(+)  - 
(+)  - 
(+)  - 
taining predominantly "yA-anti-A and anti-B but regularly increased the ag- 
glutination produced by "yG- or "~,M-anti-A  and anti-B. 
When whole colostrum was used as a source of anti-A or anti-B antibodies 
it was observed that two samples out of five sensitized red cells to anti-C' glob- 
ulin serum. One sample of colostrum (Tho.) giving a definitely positive result 
and one (Hol.) giving a  negative result were fractionated on DEAE-cellulose. 
In both cases the 0.1 M(a) and 0.1 M(b) fractions, containing the bulk of ~,A- 
globulin, failed to sensitize red cells to agglutination by anti-C  t globulin serum. 
The 0.3 M fraction from sample Tho. gave a positive result indicating that the 
positive result given by whole colostrum was due to an antibody eluted with 
a  buffer of higher molarity. Incidentally, the antibody eluted in this fraction 
was found to be completely inhibited by treatment with 2-mercaptoethanol at 
neutral pH. 
Enhancement of Agglutination by Using Serum Instead of Saline as a Medium. 960  'yA-BLOOD GROUP ANTIBODIES 
--The anti-A and anti-B agglutinins present in two samples of colostrum and 
in the 0.0175, 0.08,  and 0.2 M fractions prepared from Win. serum were tested. 
It was found that the fiter of the antibody present in colostrmn, in the0.0175 
and in the 0.08 ~  fractions, but not that present in the 0.2 M fraction, was 
enhanced by using serum instead of saline as a  diluent.  The results of testing 
one sample of colostrum and the fractions obtained from semrn using DEAE- 
cellulose are shown in Table V. 
Effect of A  Substance on 3,A-Anti-A.--The anti-A agglutinin present in one 
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Fzo. 2. Effect of varying amounts of purified human A substance (given as dilutions of a 
solution containing 2 mg/ml) on 3'G-, h'A-, and 3,M-anti-A agglutinins. 
0.0175 ~ and 0.2 x¢ DEAE fractions, containing predominantly 3"G- and 3'M-anti-A re- 
spectively; colostrum predominantly "yA-anti-A;  see text. 
colostrum (Roy.) and in the 0.0175  and 0.2 M fractions prepared from serum 
Bak.  was tested before and after the addition  of various dilutions  of A  sub- 
stance. It was found that 5'A-anti-A was less easily neutralized by A substance 
than was "yM-anti-A, but it was more easily neutralized than was 3,G-anti-A; 
see Fig. 2. 
Effect  of Heating "yA-Anti-A  at 56°C for  Various  Periods.--The results  of 
testing anti-A agglutinin present in colostrum and in the 0.0175, 0.08, and 0.2 
fractions prepared from Bak. serum before and after heating at 56°C for 1, 
2, and 3 hr are shown in Fig. 3. The anti-A agglutinin titer of the fractions con- 
taining the bulk of 5'G- and 5"A-globulins  and of colostrum was unaffected by ADINOLYI~ MOLLISON~ POLLEY~ AND ROSE  961 
heating  at 56°C  for 3  hr whereas the titer of the 0.2  ~r fraction  (containing 
"yM-anti-A) fell progressively. 
Effect of Treating ~fA-Anti-A and Anti-B with 2-Mercaptoethanol at Neutral 
pH.--Three samples of colostrum and the 0.08 ~  fractions prepared from Win. 
and Bak. sera were tested before and after treatment with 2-ME; as a  control 
the fractions containing the bulk of ~/G-- and "),M- anti-A or anti-B were also 
tested. 
The agglutinin present in the colostrum and in the 0.08 ~  fraction was par- 
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Fzo. 3. Effect of heating at 56°C for periods of up to 3 Jar on agglutln!ns in colostrum 
('/A-anti-A) and in DEAE fractions conta~ing predominantly 7G (0.0175 2), 7A (0.08 M), 
and 7M (0.2 2). 
tially inhibited by the treatment whereas, as expected, the antibody present in 
the 0.0175 m fraction was not inhibited and that present in the 0.2 ~  fraction 
was inhibited.  The results of testing three samples of colostrum and the 0.08 
M fraction prepared from serum Win. are shown in Table VI. 
Tests  on Eluates  Prepared from Antibodies  in Colostmm.--As  described  in 
Methods an anti-A eluate was prepared from colostrum, using two successive 
elutious, the first being made into 10% albumin. The amount of ^/A-glcbulin 
in  the  second  eluate  was  estimated  by the  inhibition  of antiglobulin  serum 
method using as a  control an eluate made in the same way but from group O 
red cells. The sample of colostrum had an anti-A titer of 1000 and the second 
eluate a  titer of 32.  The second eluate was estimated to contain 12 pg per rnl 962  ')"A-BLOOD GROUP ANTIBODIES 
~,A-globulin but no detectable "yG-globulin.  The control eluate from group O 
red cells contained less than 0.1 gg per ml 3'A-globulin. 
Sera Containing Anti-Rh.--All of the 32 sera containing anti-D which were 
tested were "incomplete" and all sensitized red cells to agglutination by anti- 
~,G-globulin. All the sera were tested for their ability to sensitize red cells to 
agglutination by anti--3,A-globulin serum, in each case using the four different 
anti--'rA-sera described in Methods. 
Of  10 sera with ~G-anti-Rh  titers of 256  to 2000,  1  (Avg.)  sensitized red 
cells to agglutination by anti,A; of 10 with ~,G--anti-Rh titers of 32 to 128, 2 
(Gar.  and  Hol.)  sensitized  red  cells to agglutination  by anti-3'A;  and  of  10 
sera with "rG-anti-Rh titers of 4 to 16 and 2 further sera, not titrated, none 
sensitized red cells to agglutination by anti-TA. 
TABLE  VI 
Effect of Treatment with g-Memaptoetkanol on Anti-A and Anti-B Antibodies Present in 
Colostrum  and in the O.Og M Fraction Prepared from Serum "Win." 
Colostrum Roo  ....................... 
Colostrum McD ...................... 
Colostrum Thu  ...................... 
Serum "Win." 0.08 ~s fraction ......... 
ABO 
group 
Anti-A* 
Control  [  2-ME 
51  4O 
66  36 
98  40 
.•° 
Anti-B* 
Control 
60 
°.° 
42 
2-ME 
.°• 
29 
•°° 
25 
* The antibody titer is expressed as a "score". The antibody was incubated with 2-ME 
at neutral pit as described  in Methods and as a control was incubated simply with buffer. 
•  •  •,  Not tested. 
Of the 3 sera which sensitized red cells to agglutination by anti-~/A,  2 (Gar. 
and  Hol.)  came from women immunized by pregnancy alone and  1 from a 
woman (Avg.) immunized originally by pregnancy but subsequently reimmu- 
nized with deliberate injections of Rh-positive red cells. 
The subject, Gar., had had three pregnancies, the last of which resulted in 
the birth of an infant with moderately severe hemolytic disease; the indirect 
antiglobulin titer of this serum with anti-'yG was 128 and with anti,A, 4. 
The subject, Hol., had had five pregnancies• The second and fifth infants 
were severely affected with hemolytic disease and the third and fourth mod- 
erately affected; the indirect antiglobulin titer of the serum with anti-'yG was 
64 and with anti-~,A,  2. 
As described earlier, numerous blood samples were available from the subject 
Avg. as she was undergoing regular venesection. When testing a sample taken 
from this patient in January 1964, it was realized that part of the antibody was 
"rA-globulin; fortunately many earlier samples had been kept and it was thus ADINOLFI,  MOLLISON, POLLEY~ AND ROSE  963 
possible to trace the development of the antibody; the results are illustrated in 
Fig. 4. As Fig. 4 shows, no antibody could be detected in the samples taken 
after the first two injections of Rh-positive ceils but ~A-anti-D  was readily 
detectable in the sample taken 5 wk after the third injection. After a further 
3 wk the antibody was only just detectable and 6 wk after this, was no longer 
detectable. Following the fourth injection of Rh-positive red cells, the antibody 
was detectable again by the end of 9 days at the same titer as following the 
third injection, but this time the titer was maintained so that, about 3 months 
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FIG. 4.  Estimates of 3'G-- and "yA-aati-Rh in a patient (Avg.) immunized before 1950 by 
pregnancy and possibly also by transfusion. 1, 2, 3, and 4 indicate times at which intravenous 
injections of I ml of Rh-posifive red cells were given. 
after the third injection, it was still 16. After a further 6 months the titer had 
rather surprisingly risen to 64 although after 18 more months it was back again 
to 16. Thus 3 yr after the last R_h-positive  stimulus the ~/A-antibody was still 
readily detectable. 
Samples of serum from Gar., Hol., and Avg. were fractionated on DEAE- 
cellulose and it was confirmed that the 0.08 ~  fraction contained the bulk of 
the ~A-antibody. 
It was noted that in all three cases the undiluted 0.08 ~t fraction sensitized 
red cells more strongly to agglutination by anti-$A-globulin serum than did 
undiluted whole serum although the end point of the titer of ~/A-antibody was 
the same in whole serum as in the fraction. 
Of the remaining 29 sera containing anti-D, 12 were fractionated on DEAE- 
cellulose but in no case did the 0.08 M fraction, containing the bulk of the "yA- 964  ~A-BLOOD  GROUP  ANTIBODIES 
globulin, sensitize red cells to agglutination by anti--3,A-globulin serum. The 
sera fractionated included 10 out of 14 which had titers of 128 or more. 
The two samples of serum containing incomplete anti-c had  titers of 2000 
and  128  respectively when tested by the indirect antiglobulin method using 
anti-,,(G but  neither serum  sensitized  red  cells to agglutination  by anti-~,A; 
both sera were fractionated on DEAE-cellulose and in both cases the 0.08 M 
fraction failed to sensitize red cells to agglutination by antiqA. 
Tests on Sabiva and Colostrum  from Patients with Anti-D in their Serum.--Sa- 
liva from Avg. whose serum at the time contained ~/A-anti-D  with a  titer of 
16 and qcG--anti-D with a titer of 2000 contained no detectable anti-D although 
it contained anti-B agglutinin with a titer of 1 in 16. 
Colostrum was obtained from 5 women whose serum contained ~G-anti-D 
with fiters ranging from 8 to 64; the serum of 1 woman (Hol.) contained ~,A- 
anti-D.  In no case was  anti-D  detected in the  colostrum although  in  every 
case anti-A, anti-B, or both agglutinlns were present. Saliva obtained from 2 
of these women contained anti-A and anti-B but no anfi-D. 
Sera Containing other Blood Group Antibodies.--Serum  from the donor Cri. 
with an anti-Le  ~ titer of 128 and an anti-Le  b titer of 32 contained only q,M- 
antibody, all activity being recovered in the 0.2 M fraction. 
Serum from Bur.,  with  an anti-Le  a titer of 128,  contained predominantly 
~,M-globulin as judged by the fact that it sensitized red cells to agglutination 
by anti-~M  (10) but not by anti--0,A- or "yG-globulin serum; when the serum 
was fractionated on DEAE-cellulose most of the activity was recovered in the 
0.2 ~r fraction although some was recovered in the 0.08 ~  fraction; this latter 
fraction did not sensitize red cells to agglutination by anti-'yA (or by anti-~,G) 
and the presence of anti-Le  a could be deduced only by showing that the frac- 
tion would bring about complement binding to Le(a+) but not Le(a--) red 
cells. 
Serum from donor Spe.  (anti-Le  = titer 32) was selected because, unlike any 
other Lewis antibodies investigated in this laboratory, it sensitized red  cells 
to agglutination by anti-TG-globulin sera. It did not sensitize red cells to ag- 
glutination by anti-TA-globulin. 
DISCUSSION 
The finding of an example of "rA-anti-Rh(D) made it possible to apply the 
inhibition of antiglobulin serum method to estimating ~/A in colostrum, saliva, 
serum,  and  serum fractions.  The specificity of the method is  shown  by the 
finding (as expected from previous work) that cord serum contained less than 
1% of the amount of -/A-globulin present in adult serum. The fact that colos- 
trum was found to contain 50 to 100% and saliva 20% of the amount  of "rA 
in normal serum agrees well with previously published results (4). 
Anti-A and anti-B in colostrum were found either entirely or mainly in the 
DEAE  fractions containing the bulk  of the "yA-globulin.  Evidence that  the ADINOL~I~ ~IOLLISON~ POLLEY~ AND ROSE  965 
antibodies themselves are ~,A depends on two findings: first that the agglutina- 
tion produced by the antibodies was enhanced by anti-~,A but not by anti~G 
or anti-'yM; second that anti-A eluted from red cells incubated with anti-A- 
containing colostrum was found to be entirely ~A-globulin. 
The finding that anti-A and anti-B titers are often higher in colostrum than 
in serum from the same subject whereas the concentration of ~,A is somewhat 
higher in serum, and that ~A-anti-A may be present in colostrum but absent 
from the corresponding serum, emphasises that the ~,A in colostmm is not just 
a  "filtrate" of serum.  For this reason  it cannot be  assumed  that the char- 
acteristics  of ~,A-antibodies in colostrum will necessarily be the same as those 
of the corresponding ~,A-antibodies in the serum although in the present work 
no discrepancies were observed. 
The  present  observation  that  "},A-anti-A and  anti-B  are  not  hemolytic 
agrees with previous  work (2, 3) as does the observation that the antibodies 
are partially inactivated by 2-mercaptoethanol  (2, 3) and that in their relative 
ease of neutralization by A substance and the degree to which agglutination is 
enhanced by a medium of serum rather than saline, they are intermediate in 
behavior between ~,M- and ,yG-anti-A and anti-B (2). 
The  present  finding  that  the  agglutination produced by ~,A-anti-A  and 
anti-B is enhanced by anti~A agrees with that of Ishizaka et al. (3), although 
Rawson and Abelson (2) found no enhancement. 
The present observation that only 3 out of 32 anti-Rh sera sensitized  red 
cells to agglutination by an anti-~,A-globulin serum is dearly at variance with 
that of Prager and Bearden (19) who found that 15 out of 15 Rh antibodies 
sensitized red cells to agglutination by an anti-~,A-globnlin serum. To explain 
the discrepancy  one can only suggest either that the sera used in the present 
work gave false negative results  although this seems a little unlikely since 4 
different anti-'~,A-sera  were  used  and  some  clear-cut  positive  results  were 
observed;  or that the serum used by Prager and Bearden cross-reacted  with 
"yG-globulin. 
The present findings seem also to be at variance with those of Dodd and 
Wilkinson  (20) who found that many Rh  antibodies  were  partly ~,A. The 
technique used by these authors was  to fractionate the anti-R_h-containing 
serum  on DEAE-cellnlose  and  to show  that the serological activity of  the 
fraction rich in ~A was inhibited by the addition of anti--~,A-globulin serum. 
The  addition of anti-~,G-globulin  serum  to  the fraction also  inhibited the 
reaction suggesting  the possibility  that the inhibition produced by anti~A 
was due, at least partly, to a cross-reaction  with ~,G-globulin. One sample of 
anti-Rh found by Dodd and Wilkinson  to be partly ~/A was  kindly made 
available  to us by the authors but did not in our hands sensitize red cells to 
any of the examples of anti--~'A-globulin serum which we used. It is of course 
possible  that  the method used  by  these  authors  was  capable  of detecting 
examples of ~/A-anti-Rh not detectable by the method used in the present work. 966  ~A-BLOOD GROUP  ANTIBODIES 
Studies in the present work on the patient Avg. who formed 3,A-anti-Rh 
after  repeated  stimulation  provided  new  information about  the  ease  with 
which "yA-antibody is formed in relation to "gG and on the persistence of the 
antibody in the serum. Thus an injection of Rh-positive cells which was suffi- 
cient to boost the titer of preexisting'yG-anti-Rh to a high level failed to bring 
about the formation of detectable 3,A-anti-Rh although after a further booster 
injection some -gA-anti-Rh became detectable. During the following few weeks 
the "yA-anti-Rh fell to an undetectable level while the 3,G-anti-Rh remained 
at  the same high level.  Following a  third booster injection the -gA-anti-Rh 
reappeared, and after a fourth injection it reached a  steady level at which it 
remained for 3 yr without further stimulation. 
SUMMARY 
The serological characteristics of 7A-anti-A and anti-B were studied using, 
as a source, either colostrum, or fractions relatively rich in 3'A obtained from 
selected potent antisera. ,yA-anti-A and anti-B were never hemolytic nor did 
they  sensitize  red  cells  to  agglutination by  anticomplement  globulin  sera. 
3,A-anti-A, like ~,G-anti-A and unlike 3,M-anti-A was unaffected by heating 
at 56°C for 3 hr. On the other hand in the following three characteristics the 
behavior of 3'A fell between that of ~G- or 3,M-anti-A: sensitivity to inactiva- 
tion by 2-mercaptoethanol, ease of neutralization by A substance and degree of 
enhancement of agglutination in a medium of serum rather than saline. The 
agglutination produced by "yA-anti-A was regularly enhanced by addition of 
anti--yA-globulin serum. 
In searching for ~¢A-blood group antibodies of other specificities  the following 
sera were tested: anti-i) (32 examples); anfi-c (2  examples); anti-Le  = or -Le  b 
(3  examples); anti-K  (3  examples);  anfi-Fy" (3  examples),  and anti-Jk  = (3 
examples). Only 3 sera, all containing anti-i), sensitized red cells to agglutina- 
tion by anti-~,A.  There  were no discrepancies between results obtained with 
four different anti-~,A-globulin sera.  Approximately half the  sera  were frac- 
fionated on I)EAE-cellnlose, and the fractions rich in ~'A tested for their ability 
to sensitize red cells  to agglutination by anti-TA; no additional examples of 
~,A-antibodies were detected. 
One of the three examples of "yA-anti-I) appeared in the serum of a woman 
during the course of deliberate reimmunization. "yA-anti-D appeared only after 
three  intravenous injections of  red  cells  although the 3,G-anti-D  titer  rose 
considerably after a single injection. 3 yr after a fourth injection of Rh-positive 
cells ,yA-anti-D, as well as 7G-anti-i), was still present in the serum. 
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